CYTOCHROME C REDUCTASE TYPE I(9027-14-9)
- Name: CYTOCHROME C REDUCTASE TYPE I
- Synonyms:Cytochromec reductase; Cytochrome c reductase (NADH); DPNH-cytochrome c reductase;Dihydronicotinamide adenine dinucleotide-cytochrome c reductase;Diphosphopyridine nucleotide-cytochrome c reductase; NADH-cytochrome creductase; NADH-dependent cytochrome c reductase; NADH-ferricytochrome coxidoreductase; Reduced nicotinamide adenine dinucleotide-cytochrome creductase
- Molecular Formula:NULL
- Molecular Weight:0
- CAS Registry Number:9027-14-9
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.9027-14-9 Manufacturer supply CAS 9027-14-9 with best quality
Assay:99% Appearance:White powder Package: [Packaging]20mg, 50mg,100mg,1g,10g,100g,according to customers' requirements Storage: should be stored in a well-closed container at low temperature, keep away from moisture, heat and light. Transportation:1. Samples 1kg-10kg are shipped by international express. 2. 50kg-100kg of goods are transported by dedicated line logistics. 3. Cargo 100kg-1ton is transported by dedicated line logistics. Application:Chemical raw materials, pharmaceutical intermediates, cosmetic raw materials, etc.
Min. Order:1Kilogram
Supplier:Zhuozhou Wenxi import and Export Co., Ltd [
China (Mainland)]
CAS No.9027-14-9 CYTOCHROME C REDUCTASE TYPE I FROMPORCIN E HEART CR
Assay:97% Appearance:powder Package:according to the clients requirement Storage:Room temperature with sealed well Transportation:by sea or by air Application:Use as primary and secondary intermediate
Min. Order:0
Supplier:BOC Sciences [
United States]

Other Product
- 60959-10-6/N-(4,5-Dimethyl-3-isoxazolyl)-N-methylimidodicarbonimidic diamide monohydrochloride
- 113963-41-0/Andrographidine E
- 156619-66-8/13-hydroxy-8,16-bis(2-oxopropyl)-1,9-dioxacyclohexadecane-2,5,10-trione
- 219566-63-9/Spiro[2,5-cyclohexadiene-1,10'(6'H)-pyrrolo[4,3,2-de][1,7]phenanthroline]-4,6'-dione,3,5-dibromo-2',3',5',7',8',9'-hexahydro-5'-methyl-
- 68515-02-6/Rosin, polymer with isophthalic acid and pentaerythritol
- 53006-55-6/[4-(3-methyl-1H-pyrazol-1-yl)phenyl]amine
- 23034-56-2/6-Diazo-N-(9-ethyl-9H-carbazol-3-yl)-5,6-dihydro-5-oxo-1-naphthalenesulfonamide
- 78232-29-8/3-methyl-1,1-diphenyl-4-pyrrolidin-1-ylbutan-1-ol hydrochloride
- 6148-86-3/1-(4-benzylpiperidin-1-yl)-2,2-diphenylethanone
- 72017-88-0/Bis(thiocyanic acid)oxohafnium salt
- 107659-21-2/2-(2,4-dichlorophenyl)-2-hydroxy-1-(1H-imidazol-1-yl)heptan-3-one
- 67906-29-0/Sodium 1-(2-ethoxyethyl) 10-hydroxy-9-sulphonatooctadecanoate
- 106268-97-7/(2S,3S)-TRANS-3-METHYLOXIRANE-2-METHYL 4-NITROBENZOATE
- 36727-95-4/3-(4-methylphenyl)glutamic acid
- 80348-35-2/1-[3-(ethylsulfanyl)-5,5-dimethylcyclohex-2-en-1-ylidene]pyrrolidinium
- 6631-29-4/N-(benzenesulfonyl)benzohydrazide
- 133943-48-3/S 2765
- 5175-72-4/3,6-di-tert-butyl-4,5-dimethoxycyclohexa-3,5-diene-1,2-dione
- 66835-37-8/(2S,4aα,6aβ,10aα)-2β-(3-Furyl)dodecahydro-9α-hydroxy-10bβ-methyl-4,6-dioxo-2H-naphtho[2,1-c]pyran-7α-carboxylic acid methyl ester
- 9027-14-9/CYTOCHROME C REDUCTASE TYPE I
- 760-84-9/L-Leucine hydrochloride
- 91990-66-8/5-heptyl-4-hexyl-2,4-dihydro-3H-pyrazol-3-one
- 66068-76-6/(S)-(+)-(1-AMINOETHYL)PHOSPHONIC ACID
- 77203-45-3/6-({[4-(4-methoxyphenyl)-1,3-thiazol-2-yl]amino}methylidene)cyclohexa-2,4-dien-1-one
- 7234-10-8/(4-chloro-1,4-dimethylcyclohexyl)(phenyl)methanone
- 3897-15-2/1-methyl-5-phenyl-1,5-dihydro-4,1-benzoxazepin-2(3H)-one
- 62268-30-8/3-[(2-chloro-1,1-dioxido-1-benzothiophen-3-yl)amino]propan-1-ol
- 5962-60-7/1,3,2-Dithiastibolane
- 63886-29-3/1-(8-chloro-5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)pyrrolidine hydrochloride
- 3125-77-7/1 3-PHENYLENE DIISOTHIOCYANATE 97